fluorodeoxyglucose f18 has been researched along with Digestive System Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, MA; Bradley, W; Kilcoyne, A; Kurra, V; Lee, SI; Mojtahed, A | 1 |
| Kim, CK; Zukotynski, K | 1 |
2 review(s) available for fluorodeoxyglucose f18 and Digestive System Disorders
| Article | Year |
|---|---|
Abdominal immune-related adverse events: detection on ultrasonography, CT, MRI and 18F-Fluorodeoxyglucose positron emission tomography.
Topics: Digestive System Diseases; Fluorodeoxyglucose F18; Humans; Immunotherapy; Magnetic Resonance Imaging; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2021 |
Abdomen: normal variations and benign conditions resulting in uptake on FDG-PET/CT.
Topics: Abdomen; Abdominal Fat; Abdominal Muscles; Artifacts; Digestive System Diseases; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed; Urologic Diseases | 2014 |